drugset / Trial / NCT03905304
Efficacy and Safety of MEDITOXIN® in Cervical Dystonia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to test the hypothesis that the efficacy and safety of Meditoxin® are not inferior to Botox®'s in the treatment of Cervical Dystonia.
Timeline
- Start
- 2013-01-09
- Primary completion
- 2014-07-30
- Completion
- 2014-08-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 200 iu | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 300 iu | Intramuscular |